The aim of this work is to identify whether the digital treatment program Mage-tarmskolen has an effect on patients with IBS. Our secondary objectives is to address multiple aspects of digital treatmtent success of the different modules. The patients will be randomized to one of four arms and will be delivered different kinds of digital treatment. All patients will have access to ask questions to a registered dietitian. Primary end point is the proportion of patients with treatment success in the low FODMAP, behavioral therapy or both groups, versus the patient education group (sham). Treatment effect is defined as an improvement of 50 points or more on the IBS severity scoring system at 3 months after treatment start compared to the score before treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
728
Module 1: Introduction to IBS by a gastroenterologist.
Module 2:Introduction to pain physiology and how the nervous system works by a physiotherapist including practical exercises.
Module 3: Evidence-based guidelines for diet and lifestyle advice (NICE Guidelines) by a clinical dietitian.
Module 4: Intervention: behavioral therapy (exposure therapy and cognitive behavioral therapy).
Module 5: Intervention: The low FODMAP diet.
Haukeland University Hospital
Bergen, Vestlandet, Norway
IBS-SSS
Treatment success is defined as an improvement of ≥50 points on the IBS severity scoring system (IBS-SSS) at 3 months after treatment start, compared to the score before treatment
Time frame: 3 months after treatment start
IBS-QOL
≥10-point increase in the IBS-Qualiy of Life (IBS-QoL) at 3 months compared to the score before treatment.
Time frame: 3 months after treatment start
HADS
≥3-point decrease in HADS at 3 months compared to the score before treatment.
Time frame: 3 months after treatment start
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.